Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Uroselective alpha1-adrenoceptor antagonists for BPH

Sep. 8, 1997

SK-946: a potent and selective muscarinic M1 receptor agonist from Sanwa Kagaku

Sep. 5, 1997

New 5-HT3 receptor ligand with agonist activity in the gut

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

SmithKline Beecham synthesizes mechanism-based HSV protease inhibitors

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

Leucomycin analogues reported by Meiji Seika

Sep. 3, 1997

Carbohydrate-based antimicrobial agents from Novo Nordisk

Sep. 3, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...